Patents by Inventor Weishun LIU

Weishun LIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fused tricyclic compounds and uses thereof in medicine
    Patent number: 12128044
    Abstract: A fused tricyclic compound and application thereof in medicine, especially as a medicament for the treatment and/or prevention of hepatitis B. Specifically, the present invention relates to a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, wherein each variable is as defined in the specification. The present invention also relates to the use of a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof as a medicament, especially as a medicament for the treatment and/or prevention of hepatitis B.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: October 29, 2024
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Jianzhou Huang, Qingyun Ren, Jinfeng Xiong, Yang Liu, Xinchang Liu, Siegfried Goldmann, Yingjun Zhang, Yifeng Wang, Weishun Liu, Fangcai Yu
  • FUSED TRICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE
    Publication number: 20210236493
    Abstract: A fused tricyclic compound and application thereof in medicine, especially as a medicament for the treatment and/or prevention of hepatitis B. Specifically, the present invention relates to a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, wherein each variable is as defined in the specification. The present invention also relates to the use of a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof as a medicament, especially as a medicament for the treatment and/or prevention of hepatitis B.
    Type: Application
    Filed: August 27, 2019
    Publication date: August 5, 2021
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Jianzhou HUANG, Qingyun REN, Jinfeng XIONG, Yang LIU, Xinchang LIU, Siegfried GOLDMANN, Yingjun ZHANG, Yifeng WANG, Weishun LIU, Fangcai YU